Literature DB >> 7554149

Description of a nonselective cation current in human atrium.

W J Crumb1, J D Pigott, C W Clarkson.   

Abstract

Ion currents were examined in isolated human atrial myocytes by using the whole-cell patch-clamp technique. When currents were recorded with a K(+)-containing pipette solution, depolarizing voltage pulses elicited a rapidly activating outward current that decayed to an apparent steady state. Exposure of cells to 10 mmol/L 4-aminopyridine markedly reduced current amplitude; however, a rapidly activating current that was approximately 30% of the steady state current amplitude remained. When pipette K+ was replaced with Cs+, a similar rapidly activating current that reversed polarity at approximately 0 mV was recorded. This current was seen in 100% of the cells tested from 17 different hearts (n = 142), and its amplitude was approximately 40% of the amplitude of the steady state current recorded in the presence of pipette K+. The current amplitude was not significantly different in cells isolated from adult (6.31 +/- 1.35 pA/pF, n = 8) and pediatric (5.54 +/- 1.04 pA/pF, n = 9) hearts. Studies designed to determine the charge-carrying species indicated that changes in bath Cl- concentration had no effect on either the amplitude or the reversal potential of this current, whereas removal of pipette Cs+ and bath Na+ dramatically reduced this current. In addition, this current was not modulated by either isoproterenol (1 mumol/L, 22 degrees C) or cell swelling. This study provides the first description of a nonselective cation current in human atrial myocytes, which may play an important role in repolarization in human atria.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554149     DOI: 10.1161/01.res.77.5.950

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  9 in total

1.  Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias.

Authors:  Ksenia Blinova; Jayna Stohlman; Jose Vicente; Dulciana Chan; Lars Johannesen; Maria P Hortigon-Vinagre; Victor Zamora; Godfrey Smith; William J Crumb; Li Pang; Beverly Lyn-Cook; James Ross; Mathew Brock; Stacie Chvatal; Daniel Millard; Loriano Galeotti; Norman Stockbridge; David G Strauss
Journal:  Toxicol Sci       Date:  2016-10-03       Impact factor: 4.849

2.  Rate-dependent blockade of a potassium current in human atrium by the antihistamine loratadine.

Authors:  W J Crumb
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

3.  Membrane currents and the resting membrane potential in cultured bovine pulmonary artery endothelial cells.

Authors:  T Voets; G Droogmans; B Nilius
Journal:  J Physiol       Date:  1996-11-15       Impact factor: 5.182

4.  Effects of the chromanol HMR 1556 on potassium currents in atrial myocytes.

Authors:  Ralph F Bosch; Alexander C Schneck; Saskia Csillag; Bernd Eigenberger; Uwe Gerlach; Joachim Brendel; Hans J Lang; Christian Mewis; Heinz Gögelein; Ludger Seipel; Volker Kühlkamp
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-11       Impact factor: 3.000

5.  Late sodium current block for drug-induced long QT syndrome: Results from a prospective clinical trial.

Authors:  L Johannesen; J Vicente; J W Mason; C Erato; C Sanabria; K Waite-Labott; M Hong; J Lin; P Guo; A Mutlib; J Wang; W J Crumb; K Blinova; D Chan; J Stohlman; J Florian; M Ugander; N Stockbridge; D G Strauss
Journal:  Clin Pharmacol Ther       Date:  2015-11-28       Impact factor: 6.875

6.  Functional transient receptor potential canonical type 1 channels in human atrial myocytes.

Authors:  Yan-Hui Zhang; Hui-Jun Wu; Hui Che; Hai-Ying Sun; Lik-Cheung Cheng; Xin Li; Wing-Kuk Au; Hung-Fat Tse; Gui-Rong Li
Journal:  Pflugers Arch       Date:  2013-05-19       Impact factor: 3.657

7.  The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate.

Authors:  P Gergely; B Nuesslein-Hildesheim; D Guerini; V Brinkmann; M Traebert; C Bruns; S Pan; N S Gray; K Hinterding; N G Cooke; A Groenewegen; A Vitaliti; T Sing; O Luttringer; J Yang; A Gardin; N Wang; W J Crumb; M Saltzman; M Rosenberg; E Wallström
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

8.  Comprehensive T wave morphology assessment in a randomized clinical study of dofetilide, quinidine, ranolazine, and verapamil.

Authors:  Jose Vicente; Lars Johannesen; Jay W Mason; William J Crumb; Esther Pueyo; Norman Stockbridge; David G Strauss
Journal:  J Am Heart Assoc       Date:  2015-04-13       Impact factor: 5.501

9.  Amiselimod, a novel sphingosine 1-phosphate receptor-1 modulator, has potent therapeutic efficacy for autoimmune diseases, with low bradycardia risk.

Authors:  Kunio Sugahara; Yasuhiro Maeda; Kyoko Shimano; Akira Mogami; Hirotoshi Kataoka; Kei Ogawa; Kumiko Hikida; Hiroshi Kumagai; Mahoko Asayama; Toshinobu Yamamoto; Tomohiko Harada; Pingping Ni; Shinsuke Inoue; Atsuhiro Kawaguchi
Journal:  Br J Pharmacol       Date:  2016-11-17       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.